BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
BioTelemetry (BEAT) Tops Q2 EPS by 19c
July 30, 2020 4:16 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.35, $0.19 better than the analyst estimate of $0.16. Revenue for the quarter came in at $99.1 million versus the consensus estimate of $89.52 million.
President and CEO Commentary
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:
Due to the unwavering commitment of the entire BioTelemetry team, we continued to successfully navigate the current external... More
